Synthetic biology is redefining drug delivery, enabling breakthroughs in precision, targeting, and bioavailability. But what does synthetic biology really mean in this space? This panel brings together a diverse group of entrepreneurs and pharmaceutical leaders to discuss how they integrate synthetic biology to overcome key delivery challenges. Panelists will also explore the strategic questions of building a drug delivery company: Should they develop their own therapeutics or partner with pharma? How do they avoid commoditization and create lasting value? Join us for a dynamic discussion at the intersection of science and strategy in next-generation drug delivery.